PK Consumer Health Appoints CEO Lister

NEW YORK, Sept. 28, 2026 /CourierPR/ -- PK Consumer Health, a European consumer health group comprising Lucovitaal, Puhdistamo, and HealthAid, has appointed Neil Lister as its new Chief Executive Officer. The appointment comes as the company enters its next phase of development, focused on accelerating organic growth across its existing businesses, strengthening group-wide capabilities, and selectively pursuing additional growth opportunities in the European consumer health market.

Lister, who brings more than 25 years of experience across consumer health and consumer goods, has held senior leadership roles at Perrigo, Omega Pharma, and Procter & Gamble. His experience spans brand building, commercial growth, innovation, and business transformation. Lister has led businesses across Europe and other international markets, including in countries such as Finland, the UK, and more than 30 other countries.

Avista Healthcare Partners, the private equity firm that backs PK Consumer Health, has also expressed its confidence in Lister.

PK Consumer Health is a European consumer health group comprising PK Benelux and its flagship Lucovitaal brand, Puhdistamo in Finland, and HealthAid in the UK. The Group develops and markets vitamins, minerals, supplements, and other consumer health products across drugstore, grocery, pharmacy, and e-commerce channels. Its businesses combine strong local market positions with capabilities spanning product innovation, digital commerce, and international distribution. PK also supplies white-label and private-label medical devices to customers in more than 30 countries.

Avista Healthcare Partners, founded in 2005 by Thompson Dean and David Burgstahler, is a leading New York-based private equity firm with over $10 billion invested in more than 50 growth-oriented healthcare businesses globally. The firm targets healthcare product and technology businesses with clear scale potential across four sub-sectors experiencing strong tailwinds. Avista partners with businesses that feature strong management teams, stable cash flows, and robust growth prospects.

Lister's appointment comes as PK enters its next phase of development, focused on accelerating organic growth across its existing businesses, strengthening group-wide capabilities, and selectively pursuing additional growth opportunities in the European consumer health market. The appointment of Lister as CEO marks a significant step for PK Consumer Health, as the company looks to build on its strong foundations and capitalize on the significant opportunities ahead.